EX-23.1 4 ex23_1xfinalconsentx2022.htm EX-23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statements (Nos. 333-237413, 333-251367, 333-260859 and 333-267351) on Form S-3 and (Nos. 333-216112, 333-223672, 333-230271, 333-237165, 333-250906, 333-254771, 333-263490 and 333-266895) on Form S-8 of our report dated March 9, 2023 with respect to the consolidated financial statements of Viridian Therapeutics, Inc.
/s/ KPMG LLP
Boulder, Colorado
March 9, 2023